Peptic ulcer risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Risk Factors== | ==Risk Factors== | ||
The most potent risk factor | The most potent risk factor | ||
Common risk factors in the development of peptic ulcer include: | Common Riskin the development of peptic ulcer disease is an infection from [[Helicobacter pylori|Helicobacter pylori.]] Other risk factors include chronic use of [[NSAIDs]], [[tobacco smoking]], and family history of peptic ulcer and psychological and nosocomial stress | ||
Common risk factors in the development of peptic ulcer include:<ref name="pmid11809181">{{cite journal |vauthors=Huang JQ, Sridhar S, Hunt RH |title=Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis |journal=Lancet |volume=359 |issue=9300 |pages=14–22 |year=2002 |pmid=11809181 |doi=10.1016/S0140-6736(02)07273-2 |url=}}</ref><ref name="pmid11336566">{{cite journal |vauthors=Ballinger A, Smith G |title=COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention |journal=Expert Opin Pharmacother |volume=2 |issue=1 |pages=31–40 |year=2001 |pmid=11336566 |doi=10.1517/14656566.2.1.31 |url=}}</ref><ref name="pmid1855677">{{cite journal |vauthors=Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML |title=Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study |journal=Gut |volume=32 |issue=7 |pages=730–4 |year=1991 |pmid=1855677 |pmc=1378985 |doi= |url=}}</ref><ref name="pmid1670734">{{cite journal |vauthors=Laporte JR, Carné X, Vidal X, Moreno V, Juan J |title=Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding |journal=Lancet |volume=337 |issue=8733 |pages=85–9 |year=1991 |pmid=1670734 |doi= |url=}}</ref><ref name="pmid12948263">{{cite journal |vauthors=Wachirawat W, Hanucharurnkul S, Suriyawongpaisal P, Boonyapisit S, Levenstein S, Jearanaisilavong J, Atisook K, Boontong T, Theerabutr C |title=Stress, but not Helicobacter pylori, is associated with peptic ulcer disease in a Thai population |journal=J Med Assoc Thai |volume=86 |issue=7 |pages=672–85 |year=2003 |pmid=12948263 |doi= |url=}}</ref> | |||
*Helicobacter pylori infection | |||
*Chronic use of NSAIDs | |||
*Family history of peptic ulcer | *Family history of peptic ulcer | ||
| Line 17: | Line 19: | ||
Less common risk factors in the development of peptic ulcer disease include: | Less common risk factors in the development of peptic ulcer disease include: | ||
*Tobacco | *Tobacco | ||
* | *Alcohol | ||
* | *Psychological stress | ||
*Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and coagulopathy | *Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and coagulopathy | ||
*Rare conditions associated with gastric acid hypersecretion, such as Zollinger-Ellison syndrome, mastocytosis, or a retained antrum following partial gastrectomy gastrinoma or multiple endocrine neoplasia types I (MEN-I), Antral G cell hyperplasia, Basophilic leukemias, Short bowel syndrome | *Rare conditions associated with gastric acid hypersecretion, such as Zollinger-Ellison syndrome, mastocytosis, or a retained antrum following partial gastrectomy gastrinoma or multiple endocrine neoplasia types I (MEN-I), Antral G cell hyperplasia, Basophilic leukemias, Short bowel syndrome | ||
Revision as of 22:10, 28 November 2017
|
Peptic ulcer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Surgery |
|
Case Studies |
|
2017 ACG Guidelines for Peptic Ulcer Disease |
|
Guidelines for the Indications to Test for, and to Treat, H. pylori Infection |
|
Guidlines for factors that predict the successful eradication when treating H. pylori infection |
|
Guidelines to document H. pylori antimicrobial resistance in the North America |
|
Guidelines for evaluation and testing of H. pylori antibiotic resistance |
|
Guidelines for when to test for treatment success after H. pylori eradication therapy |
|
Guidelines for penicillin allergy in patients with H. pylori infection |
|
Peptic ulcer risk factors On the Web |
|
American Roentgen Ray Society Images of Peptic ulcer risk factors |
|
Risk calculators and risk factors for Peptic ulcer risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overviews
Common risk factors in the development of peptic ulcer disease include infection from Helicobacter pylori, chronic use of NSAIDs, cigarette smoking, alcohol intake, family history of peptic ulcer, and age >50 years.
Risk Factors
The most potent risk factor
Common Riskin the development of peptic ulcer disease is an infection from Helicobacter pylori. Other risk factors include chronic use of NSAIDs, tobacco smoking, and family history of peptic ulcer and psychological and nosocomial stress
Common risk factors in the development of peptic ulcer include:[1][2][3][4][5]
- Helicobacter pylori infection
- Chronic use of NSAIDs
- Family history of peptic ulcer
Less Common Risk Factors
Less common risk factors in the development of peptic ulcer disease include:
- Tobacco
- Alcohol
- Psychological stress
- Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and coagulopathy
- Rare conditions associated with gastric acid hypersecretion, such as Zollinger-Ellison syndrome, mastocytosis, or a retained antrum following partial gastrectomy gastrinoma or multiple endocrine neoplasia types I (MEN-I), Antral G cell hyperplasia, Basophilic leukemias, Short bowel syndrome
References
- ↑ Huang JQ, Sridhar S, Hunt RH (2002). "Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis". Lancet. 359 (9300): 14–22. doi:10.1016/S0140-6736(02)07273-2. PMID 11809181.
- ↑ Ballinger A, Smith G (2001). "COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention". Expert Opin Pharmacother. 2 (1): 31–40. doi:10.1517/14656566.2.1.31. PMID 11336566.
- ↑ Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML (1991). "Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study". Gut. 32 (7): 730–4. PMC 1378985. PMID 1855677.
- ↑ Laporte JR, Carné X, Vidal X, Moreno V, Juan J (1991). "Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding". Lancet. 337 (8733): 85–9. PMID 1670734.
- ↑ Wachirawat W, Hanucharurnkul S, Suriyawongpaisal P, Boonyapisit S, Levenstein S, Jearanaisilavong J, Atisook K, Boontong T, Theerabutr C (2003). "Stress, but not Helicobacter pylori, is associated with peptic ulcer disease in a Thai population". J Med Assoc Thai. 86 (7): 672–85. PMID 12948263.